Back to results
US 8,524,897 B2Granted
Crystalline oxazine derivative
AssigneeNovartis AG
InventorRita Ramos
Life of this patent
Estimating the term…
Abstract
The invention relates to 5-cyano-3-methyl-pyridine-2-carboxylic acid [3-((3R,6R)-5-amino-3,6-dimethyl-6-trifluoromethyl-3,6-dihydro-2H-[1,4]oxazin-3-yl)-4-fluoro-phenyl]-amide in crystalline form, to its preparation, its medical use and to medicaments comprising said compound in crystalline form.
Claims9
A crystalline form of the compound
- which has an X-ray powder diffraction pattern with at least one, two or three peaks having angle of refraction 2 theta (θ) values selected from 8.3, 9.0, 10.9, 12.9, 13.9, 15.4, 16.2, 17.1, 18.2, and 24.5° when measured using CuKα radiation wherein said values are plus or minus 0.2° 2θ.
Dependencies are inferred from the claim text.